drugset
drugset / Trial / NCT02233296

Food-Effect Study in Healthy Participants

NCT02233296 ↗

Phase 1 Completed 30 enrolled Eli Lilly and Company CoLucid Pharmaceuticals · collab
RandomizedCrossoverOpen-labelBasic science

Summary

This study will evaluate the effect of food on the pharmacokinetics (PK) of a single dose of lasmiditan in healthy participants.

Timeline

Start
2015-01
Primary completion
2015-02
Completion
2015-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Lasmiditan Small molecule 200 mg —

Indications

No indication recorded.